Influenza A virus H1N1 vaccine - Hard To Treat Diseases
Alternative Names: Swine flu vaccine - Hard To Treat Diseases/Mellow Hope/Zhejiang Tianyuan Bio-pharmaceuticalLatest Information Update: 02 Apr 2015
At a glance
- Originator Hard To Treat Diseases
- Class Influenza A virus H1N1 vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Registered Influenza A virus H1N1 subtype
Most Recent Events
- 22 Mar 2011 Zhejiang Tianyuan Bio-pharmaceutical has been acquired by Novartis
- 19 Nov 2009 Registered for Influenza-A virus H1N1 subtype in Chile (Parenteral)
- 29 Sep 2009 Registered for Influenza-A virus H1N1 subtype in China (Parenteral)